Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Raw Materials (2020 - 2022)

Historic Raw Materials for Rapid Micro Biosystems (RPID) over the last 3 years, with Q2 2022 value amounting to $12.6 million.

  • Rapid Micro Biosystems' Raw Materials rose 5368.33% to $12.6 million in Q2 2022 from the same period last year, while for Jun 2022 it was $12.6 million, marking a year-over-year increase of 5368.33%. This contributed to the annual value of $10.1 million for FY2021, which is 5005.92% up from last year.
  • Rapid Micro Biosystems' Raw Materials amounted to $12.6 million in Q2 2022, which was up 5368.33% from $10.9 million recorded in Q1 2022.
  • In the past 5 years, Rapid Micro Biosystems' Raw Materials ranged from a high of $12.6 million in Q2 2022 and a low of $6.8 million during Q4 2020
  • Its 3-year average for Raw Materials is $9.8 million, with a median of $10.2 million in 2021.
  • Its Raw Materials has fluctuated over the past 5 years, first surged by 5005.92% in 2021, then surged by 5368.33% in 2022.
  • Quarter analysis of 3 years shows Rapid Micro Biosystems' Raw Materials stood at $6.8 million in 2020, then surged by 50.06% to $10.1 million in 2021, then rose by 23.92% to $12.6 million in 2022.
  • Its last three reported values are $12.6 million in Q2 2022, $10.9 million for Q1 2022, and $10.1 million during Q4 2021.